Navigation Links
Pharmasset to Present at Cowen & Company's Health Care Conference on Tuesday, March 18th
Date:3/10/2008

PRINCETON, N.J., March 10 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) management will present at Cowen & Company's 28th Annual Health Care Conference being held March 17-20, 2008 at Boston Marriott Copley Place in Boston, MA. Schaefer Price, Pharmasset's Chief Executive Officer, will provide an overview of the company on Tuesday, March 18, 2008 from 3:55 PM to 4:00 PM (ET) in Salon C.

To access a simultaneous webcast of Mr. Price's overview of the company via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidate
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
2. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
3. Pharmasset Reports Fiscal Year End 2007 Financial Results
4. Pharmasset Appoints Michael Rogers as Chief Development Officer
5. Pharmasset to Present at Three Investor Conferences in November 2007
6. Pharmasset Accesses up to $30 Million of Working Capital
7. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
8. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
9. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
10. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
11. Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 26, 2014 PMG Research, Inc. ... Research is a network of sites that provide clinical research ... 2 million patient lives through its partnerships with large physician ... 11 hub site locations in the Southeastern United States and ... of the board will be held by: Dr. ...
(Date:11/26/2014)... November 25, 2014 Continuing its award-winning ... earned three prestigious MarCom Awards for outstanding creative achievement ... a Platinum MarCom Award, the organization’s top honor, in ... St. Louis held in April of this year. The ... 14,000 attendees. Additionally, Nerium was awarded a Gold MarCom ...
(Date:11/26/2014)... Boston, MA (PRWEB) November 26, 2014 ... and collaboration company is proud to announce that Darren ... Development and Sales. Darren will drive the ... and positive customer experience. , Darren brings ... He has held key roles in channel operations, from ...
(Date:11/26/2014)... MINNEAPOLIS , Nov. 25, 2014 Bio-Techne ... it has appointed Robert Gavin to serve ... of the Protein Platforms Division.  Mr. Gavin will be ... business segment, which includes the ProteinSimple business acquired in ... San Jose, California -based ProteinSimple ...
Breaking Biology Technology:PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3Nerium International™ Wins One Platinum, Two Gold MarCom Awards 2SoundConnect Appoints Director of Channel Development & Sales 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3
... Neuralstem, Inc. (NYSE Alternext US: CUR) announced ... present at the 11th Annual BIO CEO & ... 2009, at the Waldorf=Astoria Hotel, New York City.(Logo: ... February 9, 2009 at 10:00 a.m. Eastern Time.The ...
... Advances, Inc. (Cancer Advances), a Cato BioVentures portfolio company, ... all the technology and intellectual property for a suite ... in three gastrointestinal cancers. Cancer Advances was created as ... products developed to inhibit the hormone, gastrin, for an ...
... First proton pump inhibitor (PPI) with a ... OSAKA, Japan, Jan. 30 Takeda Pharmaceutical ... Pharmaceuticals North America, Inc., today announced that ... approved KAPIDEX(TM) (dexlansoprazole) delayed release capsules for ...
Cached Biology Technology:Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference 2Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers 2Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers 3FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 2FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 3FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 4
(Date:11/4/2014)... at the right time might actually help boost a ... help in understanding animal populations, pest control and managing ... the journal Trends in Ecology and Evolution , ... the kind of positive population effect an overall species ... on the size and developmental stage of the creatures ...
(Date:11/4/2014)... about the way our bodies are assembled during early ... they are supposed to become a nerve or a ... correct place and alignment? Researchers at the University of ... a new study, UM researchers describe the signaling systems ... at the head-trunk region. Their discovery may have important ...
(Date:11/4/2014)...   3D scanner ... Fuel3D , a developer of 3D scanning solutions, ... $6.4 million (£4 million). This funding builds on the company,s ... and paves the way for the commercial launch of the ... round was led by Chimera Partners and will be used ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2The inside story: How the brain and skull stay together 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3
... study from Rhode Island Hospital has found that a change ... contribute to improved outcomes of the victims and to the ... enforcement officers often serve as medical first responders, there is ... or should do, at the scene of an overdose. The ...
... MedNet Solutions , a global life sciences technology ... to announce that Accelovance , an award-winning, full-service ... Vaccines and General Medicine development, has joined the ... as an iMedNet Partner will facilitate Accelovance,s ...
... of Helsinki and Folkhlsan Research Center has identified a ... breeds, the Norwegian Elkhound and the Karelian Bear Dog. ... and a candidate gene for human chondrodysplasias. The finding ... health. A genetic test can now be used to ...
Cached Biology News:Changing laws, attitudes of police response to drug overdose may lead to better outcomes 2MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program 2MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program 3New dwarfism mutation identified in dogs 2